128 related articles for article (PubMed ID: 30158421)
1. [Nephrotic Syndrome Induced by Ramucirumab for Metastatic Rectal Cancer].
Sakabe R; Shirakawa K; Yoshimura K; Otsuka H; Kuwada A; Tahara K; Hotei H; Maeda Y
Gan To Kagaku Ryoho; 2018 Aug; 45(8):1205-1207. PubMed ID: 30158421
[TBL] [Abstract][Full Text] [Related]
2. Cetuximab-induced nephrotic syndrome in a case of metastatic rectal cancer.
Ito C; Fujii H; Ogura M; Sato H; Kusano E
J Oncol Pharm Pract; 2013 Sep; 19(3):265-8. PubMed ID: 23047237
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Nephrotic Syndrome Induced by FOLFIRI plus Ramucirumab for Metastatic Descending Colon Cancer].
Shingai T; Fukuzaki T; Okimura S; Ito Y; Taniguchi Y; Fukata T; Nishida H; Takayama O; Yoshioka S; Hojo S; Ohigashi H
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2155-2157. PubMed ID: 32156863
[TBL] [Abstract][Full Text] [Related]
4. [Experience of Ramucirumab plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer in Our Hospital].
Hagino S; Miyata T; Sakamoto K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1559-1561. PubMed ID: 29394701
[TBL] [Abstract][Full Text] [Related]
5. Nephrotic syndrome associated with ramucirumab therapy: A single-center case series and literature review.
Fujii T; Kawasoe K; Tonooka A; Ohta A; Nitta K
Medicine (Baltimore); 2019 Jul; 98(27):e16236. PubMed ID: 31277139
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Nephrotic Syndrome Due to SOX plus Bmab Therapy for Liver Metastasis of Rectal Cancer].
Murase H; Iseki H; Ogawa A; Kamachi K; Mitsuoka A; Hayashi M; Seongjin P; Fukuuchi A; Kume S; Uriuda Y; Hirayama K; Negishi K
Gan To Kagaku Ryoho; 2019 Feb; 46(2):288-290. PubMed ID: 30914536
[TBL] [Abstract][Full Text] [Related]
7. [Cases of Advanced Colorectal Cancer with Nephrotic Syndrome after FOLFIRI plus Ramucirumab Administration].
Nakura M; Nojima K; Yamazaki H; Takenaka S; Watanabe T; Takeshita M; Sasaki S; Fujimura T
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1745-1747. PubMed ID: 36732986
[TBL] [Abstract][Full Text] [Related]
8. Nephrotic syndrome induced by cetuximab in a patient with metastatic colorectal cancer.
Korkmaz M; Hendem E; Karakurt Eryılmaz M; Demirkıran A; Karaağaç M; Artaç M
J Oncol Pharm Pract; 2022 Jun; 28(4):998-1002. PubMed ID: 35023411
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Radical Resection of Rectal Cancer with Multiple Liver and Lung Metastases after Preoperative Chemotherapy].
Yamashita S; Shimizu Y; Tominaga H; Kimura Y; Odagiri K; Kurokawa T; Yamaguchi M; Takahashi G; Sawada G; Moon J; Inoue M; Irei T; Nakahira S; Hatanaka N
Gan To Kagaku Ryoho; 2015 Oct; 42(10):1274-6. PubMed ID: 26489570
[TBL] [Abstract][Full Text] [Related]
10. Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer.
Mackey JR; Ramos-Vazquez M; Lipatov O; McCarthy N; Krasnozhon D; Semiglazov V; Manikhas A; Gelmon KA; Konecny GE; Webster M; Hegg R; Verma S; Gorbunova V; Abi Gerges D; Thireau F; Fung H; Simms L; Buyse M; Ibrahim A; Martin M
J Clin Oncol; 2015 Jan; 33(2):141-8. PubMed ID: 25185099
[TBL] [Abstract][Full Text] [Related]
11. Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.
Yardley DA; Reeves J; Dees EC; Osborne C; Paul D; Ademuyiwa F; Soliman H; Guthrie T; Andersen J; Krekow L; Choksi J; Daniel B; Danso M; Favret A; Oommen S; Brufsky A; Bromund JL; Lin Y; Ibrahim AB; Richards PD
Clin Breast Cancer; 2016 Dec; 16(6):471-479.e1. PubMed ID: 27569274
[TBL] [Abstract][Full Text] [Related]
12. Somatic p.T771R KDR (VEGFR2) Mutation Arising in a Sporadic Angioma During Ramucirumab Therapy.
Lim YH; Odell ID; Ko CJ; Choate KA
JAMA Dermatol; 2015 Nov; 151(11):1240-3. PubMed ID: 26422291
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Lung Metastases from Rectal Cancer Treated for Quite Long with FOLFIRI plus Ramucirumab as a Late Line of Therapy].
Yoshimatsu K; Sano M; Satake M; Imaizumi R; Ito Y; Koike T; Maeda H; Ida A; Yamada Y; Okayama S; Yokomizo H; Usui T; Shimakawa T; Katsube T; Shiozawa S
Gan To Kagaku Ryoho; 2019 Oct; 46(10):1617-1619. PubMed ID: 31631153
[TBL] [Abstract][Full Text] [Related]
14. [A case of nephrotic syndrome during TS-1 therapy after resection of rectal cancer and liver metastasis].
Sakagashira M; Yamada Y
Nihon Jinzo Gakkai Shi; 2014; 56(4):538-44. PubMed ID: 24956887
[TBL] [Abstract][Full Text] [Related]
15. Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Yılmaz S; Özçakar ZB; Taktak A; Kiremitçi S; Ensari A; Dinçaslan H; Yalçınkaya F
Pediatr Nephrol; 2016 Jun; 31(6):1029-32. PubMed ID: 26928310
[TBL] [Abstract][Full Text] [Related]
16. [A case of response to panitumumab as third-line chemotherapy for multiple liver metastases and portal venal tumor embolus of rectal cancer].
Kimura Y; Goi T; Sawai K; Iida A; Katayama K; Yamaguchi A
Gan To Kagaku Ryoho; 2012 Jun; 39(6):967-9. PubMed ID: 22705694
[TBL] [Abstract][Full Text] [Related]
17. Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J; Yoshino T; Cohn AL; Obermannova R; Bodoky G; Garcia-Carbonero R; Ciuleanu TE; Portnoy DC; Van Cutsem E; Grothey A; Prausová J; Garcia-Alfonso P; Yamazaki K; Clingan PR; Lonardi S; Kim TW; Simms L; Chang SC; Nasroulah F;
Lancet Oncol; 2015 May; 16(5):499-508. PubMed ID: 25877855
[TBL] [Abstract][Full Text] [Related]
18. Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report.
Yamada R; Okawa T; Matsuo K; Suzuki M; Mori N; Mori K
BMC Nephrol; 2019 Jan; 20(1):14. PubMed ID: 30634936
[TBL] [Abstract][Full Text] [Related]
19. [A case of rectal cancer with lung metastases responding to cetuximab].
Kawai H; Uetake H; Kobayashi H; Enomoto M; Higuchi T; Yasuno M; Iida S; Ishikawa T; Sugihara K
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2152-4. PubMed ID: 20037353
[TBL] [Abstract][Full Text] [Related]
20. Ulcerative colitis associated with nephrotic syndrome after treatment with mesalazine developed into rectal carcinoma: a case study.
Sameshima S; Koketsu S; Okuyama T; Kubota Y; Ono Y; Noie T; Oya M
World J Surg Oncol; 2016 Jul; 14(1):192. PubMed ID: 27450459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
